EDNA

EDNA is a private genomics company developing a consumer-facing platform that combines whole genome sequencing, AI-driven genetic analysis, blockchain infrastructure, and decentralized finance tools. The company’s core offering is designed to let individuals retain ownership and control of their genomic data and optionally monetize access to that data for researchers and biopharma partners. EDNA appears to position itself more as a genomics data and infrastructure company than as a therapeutic drug developer, and it does not appear to have a conventional drug pipeline. Its commercial focus is on sequencing access, secure data management, privacy-preserving data transactions, and increasing representation of underserved populations in genomic datasets. The company markets this model as a way to support precision medicine research while aligning incentives with individual data contributors.